Literature DB >> 21938453

Spontaneous closure of full-thickness macular hole in type 2 idiopathic macular telangiectasia.

Dhananjay Shukla, Ramesh Venkatesh.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21938453     DOI： 10.1007/s00417-011-1817-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  7 in total

1.  Spontaneous resolution of small stage 3 and 4 full-thickness macular holes viewed by optical coherence tomography.

Authors:  R Tadayoni; P Massin; B Haouchine; D Cohen; A Erginay; A Gaudric
Journal:  Retina       Date:  2001       Impact factor: 4.256

2.  Evolution and management of macular hole secondary to type 2 idiopathic macular telangiectasia.

Authors:  D Shukla
Journal:  Eye (Lond)       Date:  2011-01-21       Impact factor: 3.775

3.  Macular hole formation associated with idiopathic parafoveal telangiectasia.

Authors:  Jeffrey L Olson; Naresh Mandava
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-20       Impact factor: 3.117

4.  Surgery for full-thickness macular hole in patients with idiopathic macular telangiectasia type 2.

Authors:  Ninel Gregori; Harry W Flynn
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2010-07-29

5.  Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study.

Authors:  J D Gass; B A Blodi
Journal:  Ophthalmology       Date:  1993-10       Impact factor: 12.079

6.  Full-thickness macular hole formation in idiopathic parafoveal telangiectasis.

Authors:  Hideki Koizumi; Jason S Slakter; Richard F Spaide
Journal:  Retina       Date:  2007 Apr-May       Impact factor: 4.256

7.  Macular full-thickness and lamellar holes in association with type 2 idiopathic macular telangiectasia.

Authors:  P Charbel Issa; H P N Scholl; A Gaudric; P Massin; A E Kreiger; S Schwartz; F G Holz
Journal:  Eye (Lond)       Date:  2008-02-08       Impact factor: 3.775
  7 in total
  2 in total

Review 1.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

2.  Comparison of observation, intravitreal bevacizumab, or pars plana vitrectomy for non-proliferative type 2 idiopathic macular telangiectasia.

Authors:  Eric J Sigler; John C Randolph; Jorge I Calzada; Steve Charles
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-09-06       Impact factor: 3.117
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.